-
1
-
-
1542348477
-
Cancer Statistics, 2004
-
Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29. (Pubitemid 38443417)
-
(2004)
Ca-A Cancer Journal for Clinicians
, vol.54
, Issue.1
, pp. 8-29
-
-
Jemal, A.1
Tiwari, R.C.2
Murray, T.3
Ghafoor, A.4
Samuels, A.5
Ward, E.6
Feuer, E.J.7
Thun, M.J.8
-
2
-
-
0024602787
-
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study
-
DOI 10.1016/0090-8258(89)90605-7
-
Thigpen JT, Blessing JA, Homesley H, Creasman WT, Sutton G. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol 1989;33:68-70. (Pubitemid 19106626)
-
(1989)
Gynecologic Oncology
, vol.33
, Issue.1
, pp. 68-70
-
-
Thigpen, J.T.1
Blessing, J.A.2
Homesley, H.3
Creasman, W.T.4
Sutton, G.5
-
3
-
-
0025319011
-
Carboplatin therapy in advanced endometrial cancer
-
Green JB III, Green S, Alberts DA, O'Toole R, Surwit EA, Noltimier JW. Carboplatin therapy in advanced endometrial cancer. Obstet Gynecol 1990;75:696-700. (Pubitemid 20110194)
-
(1990)
Obstetrics and Gynecology
, vol.75
, Issue.4
, pp. 696-700
-
-
Green III, J.B.1
Green, S.2
Alberts, D.S.3
O'Toole, R.4
Surwit, E.A.5
Noltimier, J.W.6
-
4
-
-
0030220145
-
A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group Study
-
DOI 10.1006/gyno.1996.0227
-
Ball HG, Blessing JA, Lentz SS, Mutch DG. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol 1996;62:278-81. (Pubitemid 26274811)
-
(1996)
Gynecologic Oncology
, vol.62
, Issue.2
, pp. 278-281
-
-
Ball, H.G.1
Blessing, J.A.2
Lentz, S.S.3
Mutch, D.G.4
-
5
-
-
0030054309
-
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
-
DOI 10.1056/NEJM199601043340101
-
McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, et al. Cyclophosphamid and cisplatin compared with pacitaxel and cisplatin in patient with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1-6. (Pubitemid 26012496)
-
(1996)
New England Journal of Medicine
, vol.334
, Issue.1
, pp. 1-6
-
-
Mcguire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
Kucera, P.R.4
Partridge, E.E.5
Look, K.Y.6
Clarke-Pearson, D.L.7
Davidson, M.8
-
6
-
-
0035887303
-
Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: A phase II study
-
Hoskins PJ, Swenerton KD, Pike JA, Wong F, Lim P, Acquino-Parsons C, et al. Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study. J Clin Oncol 2001;19:4048-53. (Pubitemid 32976691)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.20
, pp. 4048-4053
-
-
Hoskins, P.J.1
Swenerton, K.D.2
Pike, J.A.3
Wong, F.4
Lim, P.5
Acquino-Parsons, C.6
Lee, N.7
-
7
-
-
0033947374
-
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: Long-term results of a phase II multicenter study
-
DOI 10.1006/gyno.2000.5827
-
Dimopoulos MA, Papadimitriou CA, Georgoulias V, Moulopoulos LA, Aravantinos G, Gika D, et al. Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study. Gynecol Oncol 2000;78:52-7. (Pubitemid 30439479)
-
(2000)
Gynecologic Oncology
, vol.78
, Issue.1
, pp. 52-57
-
-
Dimopoulos, M.A.1
Papadimitriou, C.A.2
Georgoulias, V.3
Moulopoulos, L.A.4
Aravantinos, G.5
Gika, D.6
Karpathios, S.7
Stamatelopoulos, S.8
|